The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment

Pharmacokinetic interactions between ilaprazole and clarithromycin following ilaprazole, clarithromycin and amoxicillin triple therapy

(2012) Shan Cao et al.   ACTA PHARMACOLOGICA SINICA

Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors

(2012) Daniel Sifrim et al.   GUT

How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?

(2012) Nicola de Bortoli   WORLD JOURNAL OF GASTROENTEROLOGY

Ilaprazole for the treatment of duodenal ulcer: a randomized, double-blind and controlled phase III trial

(2011) Ling Wang et al.   CURRENT MEDICAL RESEARCH AND OPINION

Overweight is a risk factor for both erosive and non-erosive reflux disease

(2011) Edoardo Savarino et al.   DIGESTIVE AND LIVER DISEASE

The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease

(2011) Edoardo Savarino et al.   DIGESTIVE AND LIVER DISEASE

Laparoscopic Antireflux Surgery vs Esomeprazole Treatment for Chronic GERD

(2011) Jean-Paul Galmiche et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of CYP2C19 Genetic Polymorphism on Pharmacokinetics and Pharmacodynamics and Pharmacodynamics of a New Proton Pump Inhibitor, Ilaprazole

(2011) Hoon Cho et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Acid inhibition effect of ilaprazole on Helicobacter pylori-negative healthy volunteers: An open randomized cross-over study

(2011) Yi Qi DU et al.   Journal of Digestive Diseases

Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients

(2011) Edoardo Savarino et al.   JOURNAL OF GASTROENTEROLOGY

Ilaprazole, a new proton pump inhibitor, is primarily metabolized to ilaprazole sulfone by CYP3A4 and 3A5

(2011) Kyung-Ah Seo et al.   XENOBIOTICA

Identification of ilaprazole metabolites in human urine by HPLC-ESI-MS/MS and HPLC-NMR experiments

(2010) Gan Zhou et al.   BIOMEDICAL CHROMATOGRAPHY

A New PPI, Ilaprazole Compared With Omeprazole in the Treatment of Duodenal Ulcer

(2010) Ling Wang et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Characteristics of Reflux Episodes and Symptom Association in Patients With Erosive Esophagitis and Nonerosive Reflux Disease: Study Using Combined Impedance–pH Off Therapy

(2009) Edoardo Savarino et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Proton Pump Inhibitors

(2009) Kwong Ming Fock et al.   CLINICAL PHARMACOKINETICS

Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease

(2009) E Savarino et al.   GUT

Randomized, parallel, double-blind comparison of the ulcer-healing effects of ilaprazole and omeprazole in the treatment of gastric and duodenal ulcers

(2009) Khek Yu Ho et al.   JOURNAL OF GASTROENTEROLOGY

Gastroesophageal Reflux and Pulmonary Fibrosis in Scleroderma

(2008) Edoardo Savarino et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Effect of CYP2C19 *2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians

(2008) Nicole G. Hunfeld et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacokinetics of the new proton pump inhibitor ilaprazole in Chinese healthy subjects in relation to CYP3A5 and CYP2C19 genotypes

(2008) Yalin Li et al.   CLINICA CHIMICA ACTA

Yield of 24-Hour Esophageal pH and Bilitec Monitoring in Patients with Persisting Symptoms on PPI Therapy

(2008) George Karamanolis et al.   DIGESTIVE DISEASES AND SCIENCES

Proton pump inhibitors: an update of their clinical use and pharmacokinetics

(2008) Shaojun Shi et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Proton pump inhibitors in GORDAn overview of their pharmacology, efficacy and safety

(2008) Vincenzo Savarino et al.   PHARMACOLOGICAL RESEARCH